ClinicalTrials.Veeva

Menu

Testicular Torsion

H

Hisar Intercontinental Hospital

Status

Completed

Conditions

Testicular Torsion and TLR 4 Was Investigated

Treatments

Genetic: Toll-like receptor 4

Study type

Interventional

Funder types

Other

Identifiers

NCT05558072
2022/18

Details and patient eligibility

About

Background:

Testicular torsion is a scrotal emergency that results in impaired blood supply to the testis and ischemia of the testis as a result of the rotation of the spermatic cord around itself. The etiology of testicular torsion is not clear, but various predisposing factors are responsible for the occurrence of testicular torsion.

Recently, with the discovery of "Toll-Like Receptors" (TLRs), new horizons have been opened in the field of innate immune system-related diseases.

Objective: To mediate the relationship between testicular torsion and TLR4 receptors.

Material-Method: Testicular specimens of patients who developed testicular ischemia after testicular torsion and underwent orchiectomy between 2012-2022 were reached. A study of TLR 4 receptors was performed in these testicular specimens. The patients were divided into two groups according to their ages newborns and adolescents.

Full description

Analysis of 32 newborns and 32 adolescents between the ages of 14 and 16 (mean age was 15.17 ± 0.98) testicular tissue lysate using Toll-Like Receptor antibody 4 (TLR4) ELISA (Enzyme-Linked ImmunoSorbent Assay).

Toll-like receptor 4 is a transmembrane protein that in humans is encoded by the TLR4 gene. Its activation leads to the production of inflammatory cytokines.

Enrollment

64 patients

Sex

Male

Ages

Under 16 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

testicular torsion

  • newborn, adolescent,

Exclusion criteria

  • orchitis, urinary infection, trauma,

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

64 participants in 2 patient groups

Group 1
Experimental group
Description:
Newborn
Treatment:
Genetic: Toll-like receptor 4
Group 2
Experimental group
Description:
adolescent
Treatment:
Genetic: Toll-like receptor 4

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems